Ignite Creation Date:
2025-12-24 @ 5:12 PM
Ignite Modification Date:
2026-01-25 @ 1:19 AM
Study NCT ID:
NCT03458650
Status:
COMPLETED
Last Update Posted:
2018-05-30
First Post:
2018-01-25
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Phase I Study of LuoXin Innovate (LXI-15028) in Healthy Chinese Subjects to Evaluate the Pharmacokinetics, Safety and Tolerability.
Sponsor:
Shandong Luoxin Pharmaceutical Group Stock Co., Ltd.
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
NE821605
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None